Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Int J Cosmet Sci ; 36(1): 102-8, 2014 Feb.
Article in English | MEDLINE | ID: mdl-26230464

ABSTRACT

OBJECTIVES: Although the mechanisms of sweating due to thermoregulation vs. stress are distinct, the antiperspirant industry focuses primarily on perspiration due to heat as their method of efficacy testing. To better understand the overall protection afforded by a 'Clinical Strength' over-the-counter antiperspirant product, we compare results from a standard hot-room study with results from two studies using the Trier Social Stress Test (TSST). METHODS: For each study, unscented antiperspirant was applied to one axilla, leaving the other untreated for internal control. The hot-room protocol involved a 40-min warm-up period with 2-20 min sweat collections at 100 ± 2 °F (35% RH). The TSST requires naïve subjects to give an impromptu speech and conduct mental arithmetic, with collections of sweat, heart rate and other biomarkers of stress before, during and after the event. RESULTS: During the TSST, heart rate and salivary cortisol data indicate significant emotional stress. Wetness results show that sweat was reduced by 69.4% in the hot-room study, compared with 83.7% and 89.3% reductions in the stress studies. CONCLUSION: We have found added value in investigating antiperspirancy from several causes of sweat production to give a more encompassing picture of the protection afforded by an antiperspirant product, specifically wetness protection from heat, activity and stress-induced sweat.


Subject(s)
Antiperspirants/pharmacology , Body Temperature Regulation , Sweating/drug effects , Humans , Social Behavior , Stress, Psychological
2.
Br J Dermatol ; 166 Suppl 1: 22-6, 2012 Mar.
Article in English | MEDLINE | ID: mdl-22385032

ABSTRACT

BACKGROUND: Individuals with axillary hyperhidrosis have much higher than average sweat rates and are often prescribed anhydrous aluminum chloride (AlCl(3)) solutions. Topical application of these solutions can be irritating to the skin, resulting in poor compliance and lower than desired efficacy. OBJECTIVE: Demonstrate the efficacy of an over the counter "clinical strength" soft-solid antiperspirant using a night time application regimen and compare to a prescription aluminum chloride (6.5%) antiperspirant using male panelists. METHODS: Gravimetric hot room efficacy testing (100 F and 35% Humidity) was performed comparing an over the counter soft-solid antiperspirant to placebo in a single test. Two separate gravimetric tests were placed comparing a prescription aluminum chloride (6.5%) antiperspirant to the same soft solid product using an intent to treat model. Skin irritation was assessed daily by a trained grader. RESULTS: Placebo testing resulted in 85% of panelists having a reduction in sweating rate greater than 50%. Comparison testing showed the over the counter soft solid reduced sweat rate by an average of 34% better than the prescription product while resulting significantly less skin irritation. CONCLUSIONS: Over the counter "clinical strength" soft-solid antiperspirants can be considered as an alternative treatment to aluminum chloride antiperspirants for the treatment of heavy sweating.


Subject(s)
Antiperspirants/pharmacology , Sweat/metabolism , Sweating/drug effects , Administration, Cutaneous , Aluminum Chloride , Aluminum Compounds/administration & dosage , Aluminum Compounds/pharmacology , Axilla , Chlorides/administration & dosage , Chlorides/pharmacology , Dermatitis, Irritant/etiology , Humans , Male , Nonprescription Drugs , Prescription Drugs , Sweat/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...